Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography
Authors:
- Elizabeth A. RaffertyERElizabeth A. Rafferty
- Stephen L. RoseSRStephen L. Rose
- Dave P. MillerDMDave P. Miller
- Melissa A. DurandMDMelissa A. Durand
- Emily F. ConantECEmily F. Conant
- Debra S. CopitDCDebra S. Copit
- Sarah M. FriedewaldSFSarah M. Friedewald
- Donna M. PlechaDPDonna M. Plecha
- Ingrid L. OttIOIngrid L. Ott
- Mary K. HayesMHMary K. Hayes
- Kara L. CarlsonKCKara L. Carlson
- Thomas M. CinkTCThomas M. Cink
- 18 May 2017
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 164 (3) , 659-666
Abstract
Purpose To determine the effect of tomosynthesis imaging as a function of age for breast cancer screening. Methods Screening performance metrics from 13 institutions were examined for 12 months prior to introduction of tomosynthesis (period 1) and compared to those after introduction of tomosynthesis (period 2, range 3–22 months). Screening metrics for women ages 40–49, 50–59, 60–69, and 70+ , included rates per 1000 screens for recalls, biopsies, cancers, and invasive cancers detected. Results Performance parameters were compared for women screened with digital mammography alone (n = 278,908) and digital mammography + tomosynthesis (n = 173,414). Addition of tomosynthesis to digital mammography produced significant reductions in recall rates for all age groups and significant increases in cancer detection rates for women 40–69. Largest recall rate reduction with tomosynthesis was for women 40–49, decreasing from 137 (95% CI 117–156) to 115 (95% CI 95–135); difference, −22 (95% CI −26 to −18; P < .001). Simultaneous increase in invasive cancer detection rate for women 40–49 from 1.6 (95% CI 1.2–1.9) to 2.7 (95% CI 2.2–3.1) with tomosynthesis (difference, 1.1; 95% CI 0.6–1.6; P < .001) was observed. Conclusions Addition of tomosynthesis to digital mammography increased invasive cancer detection rates for women 40–69 and decreased recall rates for all age groups with largest performance gains seen in women 40–49. The similar performance seen with tomosynthesis screening for women in their 40s compared to digital mammography for women in their 50s argues strongly for commencement of mammography screening at age 40 using tomosynthesis.Keywords
Funding Information
- Hologic, Inc.
- National Cancer Institute (5U54CA163316-03)
This publication has 15 references indexed in Scilit:
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2016
- Breast Cancer Screening for Women at Average RiskJAMA, 2015
- Breast-Cancer Screening — Viewpoint of the IARC Working GroupNew England Journal of Medicine, 2015
- Screening Outcomes Following Implementation of Digital Breast Tomosynthesis in a General-Population Screening ProgramJNCI: Journal of the National Cancer Institute, 2014
- Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer ScreeningRadiology, 2013
- Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational StudyAmerican Journal of Roentgenology, 2013
- Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison studyThe Lancet Oncology, 2013
- Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening ProgramRadiology, 2013
- Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 DecadesRadiology, 2011
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2009